Core Insights - Cannabix Technologies Inc. has developed an autonomous alcohol breathalyzer screening device, BreathLogix, aimed at various industries and safety settings [1][3] - The company has entered into a non-exclusive distribution agreement with Alco Prevention Canada for the North American market [1][2] - The BreathLogix device is designed for self-testing, which can enhance workplace safety and reduce costs associated with traditional testing methods [3][5] Company Overview - Cannabix Technologies focuses on developing marijuana and alcohol breath testing technologies for workplaces and law enforcement [9] - The BreathLogix device features patent-pending pre-calibrated cartridge technology, allowing for easy maintenance without costly calibration equipment [5][6] - The device can perform various types of alcohol testing, including pre-access, random, and post-incident testing [5][6] Distribution and Market Strategy - Alco Prevention has a significant presence with 4,000 points of sale and 45 agents globally, which will aid in the distribution of BreathLogix [2] - The partnership with Alco Prevention is expected to facilitate the deployment of the BreathLogix device in safety-sensitive environments such as construction sites, bars, and restaurants [3][5] - Cannabix is in discussions with additional distributors to expand its market reach beyond North America [1]